[1]
Perekhrestenko, T. et al. 2023. Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy. Experimental Oncology. 42, 2 (Jun. 2023), 144–147. DOI:https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14497.